These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37336474)

  • 1. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Li Z; Xu W; Wang L; Chai L; Ageno W; Romeiro FG; Li H; Qi X
    Thromb Haemost; 2023 Nov; 123(11):1072-1088. PubMed ID: 37336474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
    Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
    Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
    Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis.
    Zhao Y; Zhu L; Yang Y; Gao H; Zhang R
    Acta Clin Belg; 2023 Jun; 78(3):234-244. PubMed ID: 35913111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.
    Coons EM; Staubes BA; Casey AL; Elagizi-Youssef SA; Mohammed AE; Sharma N; Kline ER
    Ann Pharmacother; 2022 May; 56(5):533-540. PubMed ID: 34470525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis.
    Ng CH; Tan DJH; Nistala KRY; Syn N; Xiao J; Tan EXX; Woo FZ; Chew NWS; Huang DQ; Dan YY; Sanyal AJ; Muthiah MD
    Hepatol Int; 2021 Oct; 15(5):1196-1206. PubMed ID: 34417718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
    Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
    J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis.
    Lapumnuaypol K; DiMaria C; Chiasakul T
    QJM; 2019 Aug; 112(8):605-610. PubMed ID: 31135040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of Bleeding and Discontinuation of Direct Oral Anticoagulants in Patients With Decompensated Cirrhosis.
    Mort JF; Davis JPE; Mahoro G; Stotts MJ; Intagliata NM; Northup PG
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1436-1442. PubMed ID: 32777555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis.
    Nisly SA; Mihm AE; Gillette C; Davis KA; Tillett J
    J Thromb Thrombolysis; 2021 Oct; 52(3):817-827. PubMed ID: 33728575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
    Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
    J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
    Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
    Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.
    Qi X; De Stefano V; Li H; Dai J; Guo X; Fan D
    Eur J Intern Med; 2015 Jan; 26(1):23-9. PubMed ID: 25566699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.